Transforming the Treatment Paradigm for Patients With MDS

Rami S. Komrokji, MD, discusses the challenges of diagnosing and treating patients with MDS and the promising treatments in phase III trials.

Rami S. Komrokji, MD Released: November 20, 2020

Experts answer questions on the optimal use of oral decitabine and FLT3 inhibitors and the current management of patients with low-risk and high-risk MDS.

Guillermo Garcia-Manero, MD Rami S. Komrokji, MD Jamile Shammo, MD, FASCP, FACP Released: January 11, 2021

Download this expert-selected slide set on optimal treatments for MDS-associated anemia.

Jamile Shammo, MD, FASCP, FACP Released: December 4, 2020

Download this expert-selected slide set on optimal treatments for higher-risk MDS

Rami S. Komrokji, MD Released: December 4, 2020

Download this expert-selected slide set on optimal strategies for HMA treatment failure in MDS.

Guillermo Garcia-Manero, MD Released: December 4, 2020

Download this brief summary slide set from a live CCO presentation on optimal management of patients with myelodysplastic syndromes.

Guillermo Garcia-Manero, MD Rami S. Komrokji, MD Jamile Shammo, MD, FASCP, FACP Released: December 21, 2020

Watch this on-demand Webcast capturing a live CCO Webinar to learn the latest evidence for optimizing treatment of patients with myelodysplastic syndromes (MDS).

Guillermo Garcia-Manero, MD Rami S. Komrokji, MD Jamile Shammo, MD, FASCP, FACP Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Released: December 9, 2020 Expired: No longer available for credit